• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CMATRIX:一款使用符号矩阵表示系统进行基于生理的药代动力学建模的软件。

CMATRIX: software for physiologically based pharmacokinetic modeling using a symbolic matrix representation system.

作者信息

Ball R, Schwartz S L

机构信息

Department of Pharmacology, Georgetown University, School of Medicine, Washington, DC 20007.

出版信息

Comput Biol Med. 1994 Jul;24(4):269-76. doi: 10.1016/0010-4825(94)90023-x.

DOI:10.1016/0010-4825(94)90023-x
PMID:7842649
Abstract

Physiologically based pharmacokinetic (PBPK) modeling is based on an understanding of the physical and biological factors governing drug distribution. It is a procedure requiring composition of differential equations describing the distribution of drugs among physiologically defined compartments. CMATRIX is a program that facilitates development of PBPK models. In CMATRIX, the model is represented as a matrix of transfer parameters; the program generates a corresponding system of differential equations, and solves them numerically. This system dramatically improves the ease with which PBPK models can be developed, allowing the freedom to construct subcompartments down to the receptor level.

摘要

基于生理学的药代动力学(PBPK)建模基于对控制药物分布的物理和生物学因素的理解。它是一个需要构建微分方程来描述药物在生理定义的隔室之间分布的过程。CMATRIX是一个有助于开发PBPK模型的程序。在CMATRIX中,模型表示为转移参数矩阵;该程序生成相应的微分方程组,并对其进行数值求解。该系统极大地提高了开发PBPK模型的便利性,允许自由构建直至受体水平的子隔室。

相似文献

1
CMATRIX: software for physiologically based pharmacokinetic modeling using a symbolic matrix representation system.CMATRIX:一款使用符号矩阵表示系统进行基于生理的药代动力学建模的软件。
Comput Biol Med. 1994 Jul;24(4):269-76. doi: 10.1016/0010-4825(94)90023-x.
2
[Progress in methodology of establishing physiologically based pharmacokinetic models].[基于生理的药代动力学模型构建方法学进展]
Yao Xue Xue Bao. 2014 Jan;49(1):16-22.
3
BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.BioDMET:一种基于生理学的药代动力学模拟工具,用于评估解决复杂生物学问题的建议方案。
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):37-54. doi: 10.1007/s10928-011-9229-x. Epub 2011 Dec 10.
4
A physiologically based pharmacokinetic computer model for human pregnancy.一种基于生理学的人类妊娠药代动力学计算机模型。
Teratology. 1994 Feb;49(2):90-103. doi: 10.1002/tera.1420490205.
5
A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares.一种无需使用模拟软件即可求解基于生理的药代动力学模型的方法。
Toxicol Lett. 1996 May;85(2):113-26. doi: 10.1016/0378-4274(96)03648-x.
6
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.基于生理的药代动力学(PBPK)建模与模拟方法:对已发表模型、应用及模型验证的系统综述
Drug Metab Dispos. 2015 Nov;43(11):1823-37. doi: 10.1124/dmd.115.065920. Epub 2015 Aug 21.
7
[A physiologically based pharmacokinetic model to describe the transfer of organic solvents in the human body. Simulation of kinetic behavior of trichloroethylene using a spreadsheet program].
Sangyo Igaku. 1989 Sep;31(5):335-41. doi: 10.1539/joh1959.31.335.
8
An introduction to physiologically-based pharmacokinetic models.基于生理学的药代动力学模型简介。
Paediatr Anaesth. 2016 Nov;26(11):1036-1046. doi: 10.1111/pan.12995. Epub 2016 Aug 23.
9
Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA.使用基于生理的药代动力学(PBPK)模型预测CYP3A诱导剂对底物药物药代动力学的影响:对提交给美国食品药品监督管理局(FDA)的PBPK资料的分析
Clin Pharmacokinet. 2016 Apr;55(4):475-83. doi: 10.1007/s40262-015-0330-y.
10
A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.一个纳入弥散概念的基于生理的全身药代动力学模型:短期和长期特征
J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):27-55. doi: 10.1023/a:1011565602152.

引用本文的文献

1
Physiologically Based Pharmacokinetic (PBPK) Model for Biodistribution of Radiolabeled Peptides in Patients with Neuroendocrine Tumours.基于生理的药代动力学(PBPK)模型用于神经内分泌肿瘤患者中放射性标记肽的生物分布
Asia Ocean J Nucl Med Biol. 2016 Summer;4(2):90-7. doi: 10.7508/aojnmb.2016.02.005.
2
Whole body pharmacokinetic models.全身药代动力学模型。
Clin Pharmacokinet. 2003;42(10):883-908. doi: 10.2165/00003088-200342100-00002.